These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 36870423)

  • 1. Ocular graft-versus-host disease (oGVHD): From A to Z.
    Soleimani M; Mahdavi Sharif P; Cheraqpour K; Koganti R; Masoumi A; Baharnoori SM; Salabati M; Djalilian AR
    Surv Ophthalmol; 2023; 68(4):697-712. PubMed ID: 36870423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for the development of ocular graft-versus-host disease (GVHD) dry eye syndrome in patients with chronic GVHD.
    Wang JC; Teichman JC; Mustafa M; O'Donnell H; Broady R; Yeung SN
    Br J Ophthalmol; 2015 Nov; 99(11):1514-8. PubMed ID: 25947556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How does ocular graft-versus-host disease fit under the dry eye umbrella? A review.
    Kantor NB; Tovar A; Wang T; Galor A
    Clin Exp Ophthalmol; 2024 Mar; 52(2):167-185. PubMed ID: 38204146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular surface evaluation in allogenic hematopoietic stem cell transplantation patients.
    Vanathi M; Kashyap S; Khan R; Seth T; Mishra P; Mahapatra M; Tandon R
    Eur J Ophthalmol; 2014; 24(5):655-66. PubMed ID: 24604604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A plethora of ocular surface manifestations in a multidisciplinary ocular graft-versus-host disease unit.
    Trindade M; Rodrigues M; Pozzebon ME; Aranha FJP; Colella MP; Fernandes A; Fornazari DO; de Almeida Borges D; Vigorito AC; Alves M
    Sci Rep; 2022 Sep; 12(1):15926. PubMed ID: 36151252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on ocular graft-versus-host disease.
    Nair S; Vanathi M; Mukhija R; Tandon R; Jain S; Ogawa Y
    Indian J Ophthalmol; 2021 May; 69(5):1038-1050. PubMed ID: 33913829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A brief account on ocular graft versus host disease.
    Chatterjee D
    Indian J Ophthalmol; 2023 Apr; 71(4):1115-1122. PubMed ID: 37026242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons Learned From Ocular Graft versus Host Disease: An Ocular Surface Inflammatory Disease of Known Time of Onset.
    Quiroga-Garza ME; Ruiz-Lozano RE; Rodriguez-Gutierrez LA; Khodor A; Ma S; Komai S; Mohamed-Noriega K; Perez VL
    Eye Contact Lens; 2024 May; 50(5):212-221. PubMed ID: 38518064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lifitegrast ophthalmic solution for treatment of ocular chronic graft-versus-host disease.
    Chhabra S; Jerkins JH; Conto JE; Zellner K; Shah NN; Hari PN; Hamadani M
    Leuk Lymphoma; 2020 Apr; 61(4):869-874. PubMed ID: 31762357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular graft versus host disease in allogenic haematopoetic stem cell transplantation in a tertiary care centre in India.
    Khan R; Nair S; Seth T; Mishra P; Mahapatra M; Agarwal T; Tandon R; Vanathi M
    Indian J Med Res; 2015 Nov; 142(5):543-8. PubMed ID: 26658588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine models of graft versus host disease (GVHD): Focus on ocular GVHD.
    Steven P; Perez VL; Sharma A
    Ocul Surf; 2023 Oct; 30():179-186. PubMed ID: 37742740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Review of Ocular Graft-Versus-Host Disease.
    Munir SZ; Aylward J
    Optom Vis Sci; 2017 May; 94(5):545-555. PubMed ID: 28422804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors associated with severity of dry eye syndrome in ocular graft-versus-host disease.
    Wang JCC; Mustafa M; Teichman JC; O'Donnell H; Broady R; Yeung SN
    Can J Ophthalmol; 2020 Oct; 55(5):366-372. PubMed ID: 32439193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two case reports of continued progression of chronic ocular graft-versus-host disease without concurrent systemic comorbidities treated by amniotic membrane transplantation.
    Ikarashi H; Aketa N; Shimizu E; Takano Y; Kawakita T; Uchino Y; Matsumoto Y; Ogawa J; Tsubota K; Ogawa Y
    BMC Ophthalmol; 2021 Apr; 21(1):164. PubMed ID: 33827493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desiccating Stress Significantly Increases the Risk for Chronic Ocular Graft-versus-Host-Disease.
    Gehlsen U; Stern ME; Franklin J; Tahmaz V; Hallek M; Holtick U; Scheid C; Steven P
    Transplant Cell Ther; 2022 Nov; 28(11):782.e1-782.e7. PubMed ID: 35921986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ocular graft-versus-host disease: the path from current knowledge to future managements.
    Chiang TL; Sun YC; Wu JH; Hsieh YT; Huang WL; Chen WL
    Eye (Lond); 2023 Jul; 37(10):1982-1992. PubMed ID: 36333534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meibomian Gland Dysfunction in Ocular Graft vs. Host Disease: A Need for Pre-Clinical Models and Deeper Insights.
    Appenteng Osae E; Steven P
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eyelid metrics assessment in patients with chronic ocular graft versus-host disease.
    Giannaccare G; Bernabei F; Pellegrini M; Arpinati M; Bonifazi F; Sessa M; Versura P; Campos E
    Ocul Surf; 2019 Jan; 17(1):98-103. PubMed ID: 30321606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tear Film Immunological Profile in Patients with Ocular Graft versus Host Disease.
    Serapicos P; Kim C; Barros SL; Mendes Silva Jordão IMB; Hiyane MI; Barbosa de Sousa L; Zecchin VG; Camara NOS; de Oliveira LA
    Ocul Immunol Inflamm; 2023 May; 31(4):701-709. PubMed ID: 35404738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of IL-6, IL-10, and TNF-α in Ocular GVHD Following Allogeneic Transplantation.
    Chen Y; Zhuang X; Wang L; Xu Y; Sun Z; Ren Y; Chen F; Ma X; Tang X; Zhang X
    Ocul Immunol Inflamm; 2024 Oct; 32(8):1788-1795. PubMed ID: 38252122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.